IGF1 and chronic obstructive pulmonary disease: Despite evidence from animal models of the ability to prevent angiotensin II-induced cachexia via IGF-1 overexpression and atrogene downregulation,10 ACE inhibition was not shown to have a translational benefit in patients with COPD.